Intervention
carmustine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 8 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaNCT01769911 · 2015-02-01
WITHDRAWNGene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related LymphomaNCT00569985 · 2007-06-01
COMPLETEDAutologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaNCT00345865 · 2005-08-24
COMPLETEDChemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast CancerNCT00006123 · 2000-07-01
WITHDRAWNCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaNCT00641381 · 2000-05-10
COMPLETEDCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate CancerNCT00003400 · 1998-09-01
COMPLETEDS9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast CancerNCT00002772 · 1996-07-01
TERMINATEDHigh-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsNCT00060255 · 1991-12-01
COMPLETEDCommon conditions
Lymphoma4Breast Cancer3Adult Nasal Type Extranodal NK/T-cell Lymphoma1AIDS-related Diffuse Large Cell Lymphoma1AIDS-related Diffuse Mixed Cell Lymphoma1AIDS-related Diffuse Small Cleaved Cell Lymphoma1AIDS-related Immunoblastic Large Cell Lymphoma1AIDS-related Lymphoblastic Lymphoma1AIDS-related Peripheral/Systemic Lymphoma1AIDS-related Small Noncleaved Cell Lymphoma1Anaplastic Large Cell Lymphoma1Angioimmunoblastic T-cell Lymphoma1Cutaneous B-cell Non-Hodgkin Lymphoma1Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue1Hepatosplenic T-cell Lymphoma1HIV-associated Hodgkin Lymphoma1Intraocular Lymphoma1Leukemia1Multiple Myeloma and Plasma Cell Neoplasm1Nodal Marginal Zone B-cell Lymphoma1Noncutaneous Extranodal Lymphoma1Peripheral T-cell Lymphoma1Prostate Cancer1Recurrent Adult Burkitt Lymphoma1Recurrent Adult Diffuse Large Cell Lymphoma1
Leading sponsors
Trial status mix
COMPLETED5
WITHDRAWN2
TERMINATED1
Phase mix
PHASE24
PHASE13
NA1
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.